10-Q: Mannatech Reports Mixed Q2 Results Amidst Supply Chain Challenges and Cost Reductions

Mannatech's Q2 2024 results show a decrease in revenue due to supply chain issues, but also a reduction in operating expenses, resulting in a net loss of $0.6 million.

Summary

• Mannatech's net sales for the second quarter of 2024 decreased by 14.9% to $27.7 million compared to $32.6 million in the same period last year.
• The company's net sales for the first six months of 2024 decreased by 14.4% to $57.1 million compared to $66.7 million in the first six months of 2023.
• The decline in revenue was primarily due to supply chain constraints, back orders, and some weakening of economic conditions in Asia.
• Gross profit margins decreased by 1.4% due to supply chain disruptions, which increased fulfillment costs.
• The company reduced selling and administrative expenses by $1.4 million in payroll costs and $1.3 million in consulting fees compared to the first six months of 2023.
• Foreign currency gains of $0.9 million and $1.1 million were recorded in the quarters ended March 31, 2024 and June 30, 2024, respectively, due to the strengthening of the U.S. Dollar.
• A one-time gain of $0.2 million was recorded in the quarter ended June 30, 2024 due to the liquidation of the company's entity in Sweden.
• The net loss for the second quarter of 2024 was $0.6 million, or $0.33 per diluted share, compared to a net loss of $1.1 million, or $0.59 per diluted share, for the same period in 2023.
• Net income for the first six months of 2024 was $0.6 million, or $0.30 per diluted share, compared to a net loss of $0.5 million, or $0.27 per diluted share, for the same period in 2023.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with significant challenges in revenue and gross profit, but also some positive developments in cost reduction and foreign exchange gains. The overall sentiment is cautiously negative due to the revenue decline and supply chain issues.

Positives

• The company successfully reduced operating expenses, particularly in payroll and consulting fees.
• Foreign currency gains positively impacted the financial results.
• The net loss in Q2 2024 was lower than the net loss in Q2 2023.
• The company achieved a net income of $0.6 million for the first six months of 2024, compared to a net loss in the same period of 2023.

Negatives

• Net sales experienced a significant decrease in both Q2 and the first six months of 2024.
• Supply chain issues negatively impacted gross profit margins.
• The company experienced a decrease in revenue per active independent associate and preferred customer in the Americas and Asia/Pacific regions.
• Recruitment of new independent associates and preferred customers decreased by 13.6% in Q2 2024.

Risks

• Continued supply chain constraints could further impact revenue and profitability.
• Weakening economic conditions in Asia could lead to further sales declines.
• Failure to maintain or improve revenue compared to operational expenses could impact liquidity.
• The company may need to raise additional funds if existing capital resources are insufficient.
• The company's future access to capital markets may be adversely impacted if it fails to maintain compliance with Nasdaq listing rules.

Future Outlook

The company believes its existing liquidity and cash flows from operations are adequate to fund normal expected future business operations for the next twelve months, but acknowledges that if existing capital resources or cash flows become insufficient, they may need to raise additional funds.

Management Comments

• Management continued to prioritize the reduction of selling and administrative expenses as a countermeasure to soften the impact on profitability.
• Management has established a 2024 business reorganization plan focusing on revenue growth, margin improvement and cost control and reduction.

Industry Context

The company operates in the nutritional supplement industry, which is subject to various market risks, including changes in consumer demand, regulatory changes, and competitive pressures. The company's performance is also affected by global economic conditions and currency exchange rates.

Comparison to Industry Standards

• The company's decrease in revenue and gross profit margins is concerning, as it indicates potential challenges in maintaining market share and profitability compared to industry benchmarks.
• The company's reduction in operating expenses is a positive sign, but it needs to be balanced with efforts to drive revenue growth.
• The company's reliance on network marketing distribution channels makes it vulnerable to changes in associate recruitment and retention rates, which are key performance indicators in the direct selling industry.
• The company's performance in the Asia/Pacific region, particularly in Korea, is a significant factor in its overall results, and its ability to address supply chain issues and economic conditions in this region will be crucial for future success.
• Comparible companies in the nutritional supplement industry include Herbalife, Nu Skin, and USANA Health Sciences. These companies also face similar challenges related to supply chain, economic conditions, and regulatory changes. Mannatech's performance should be compared to these companies to assess its relative position in the market.

Management Changes

Legal Proceedings

• As of June 30, 2024, the Company had no open or pending litigation and no legal reserve was deemed necessary.

Related Party Transactions

• On April 23, 2024, the Company issued unsecured notes payable to Jade Capital, J. Stanley Fredrick, and Kevin Robbins, who are all members of the Board of Directors.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and gross profit margins.
• Employees may be affected by the cost reduction measures, including potential changes in compensation and benefits.
• Associates and preferred customers may be impacted by changes in product availability and promotions.
• Suppliers may be affected by changes in the company's purchasing patterns.

Next Steps

• The company plans to focus on revenue growth, margin improvement, and cost control through a 2024 business reorganization plan.
• The company will continue to monitor and address supply chain issues.
• The company will focus on improving the customer ordering process and software updates to improve visibility of sales associate activity.

Key Dates

Keywords

nutritional supplements, network marketing, direct selling, supply chain, financial results, revenue, gross profit, operating expenses, foreign exchange, Asia/Pacific, EMEA, Americas